Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Hướng dẫn sử dụng

Pharmedic Pharmaceutical Medicinal JSC (HNX: PMC)

81,000

(%)
04/24/2024 11:14

Open

High

Low

Vol2

Market Cap.755.94

Remain Bid1,998

Remain Ask2,898

52Wk High85,500

52Wk Low52,600

52Wk Avg Vol2,640

Foreign Buy-

Frgn Owned(%)3.39

Dividend15,600

Dividend Yield0.19

Beta0.22

EPS8,905

P/E9.10

F P/E10.38

BVPS36,325

P/B2.23

Financial ratios of latest trading date, EPS in the company's latest quarter Financial Statement
View with PMC: PAT BMP SLS HAG DBD
Trending: HPG (84,499) - NVL (72,462) - DIG (63,177) - MBB (61,218) - VND (58,699)
1 day | 5 day | 3 months | 6 months | 12 months
- Pharmedic Pharmaceutical Medicinal Joint Stock Company (PMC), formerly Pharimex Healthcare Import and Export Company, was established in 1981. In 1997, The company transformed its business model as a Joint Stock Company. Company specializes in producing and trading pharmaceutical products and materials, cosmetics, medical materials and other medical related products. Products are distributed throughout Vietnam but ... View more
DateCloseChangeVolume
04/24/202481,0000 (0.00%)2
04/23/202481,000-900 (-1.10%)300
04/22/202481,9000 (0.00%)10
04/19/202481,9000 (0.00%)1,100
04/17/202481,9001,900 (+2.38%)620
Volume: share, Price: Dong
Unit: Million Dong
Unit: Million Dong
03/18/2024PMC Dividend payment in cash with 14.00% (Tranche 2/2023) (Record date)
03/18/2024PMC Dividend payment in cash with 14.00% (Tranche 2/2023)
12/07/2023PMC Dividend payment in cash with 46.00% (Tranche 2/2023) (Record date)
12/07/2023PMC Dividend payment in cash with 46.00% (Tranche 2/2023)
11/09/2023PMC Dividend payment in cash with 80.00% (Tranche 1/2023) (Record date)
04/22/2024Resolution of Annual Shareholders' Meeting 2024
04/22/2024FS Quarter 1 of 2024
04/01/20242024 Annual Shareholders’Meeting Documents
04/16/2024Annual report 2023
03/28/2024Audited FS 2023

Pharmedic Pharmaceutical Medicinal JSC

Name: Pharmedic Pharmaceutical Medicinal JSC

Abbreviation:PHARMEDIC

Address: 367 Nguyen Trai street, Nguyen Cu Trinh Ward District 1 Ho Chi Minh

Telephone: (84.28) 3920 0300 - 3837 5300

Fax: (84.28) 3920 0096

Email:pharmedic@vnn.vn

Website:http://www.pharmedic.com.vn

Exchange: HNX

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 10/09/2009

Chartered capital: 93,325,730,000

Listed shares: 9,332,573

Shares outstanding: 9,332,573

Status: Operating

Tax code: 0300483037

Establishment license: 4261/ QÐ - UB

Issued date: 08/13/1997

Business license: 064075

Issued date: 12/09/1997

Main business scope:

- Producing and trading pharmaceutical products and materials, cosmetics, medical materials and other medical related products.

- Processing raw materials.

- Printing and pressing plastic, paper and aluminum package.

- Trading and manufacturing chemicals.

- Others under the business license.

- June 30, 1981: Pharmedic Pharmaceutical Medicinal Joint Stock Company, formerly known as Pharimex Healthcare Import and Export Company, was established;

- December 09, 1997: Equitized and renamed as Pharmedic Pharmaceutical Medicinal Joint Stock Company. Its initial charter capital was VND13 billion;

- 1999: Increased charter capital to VND20.55 billion.

- 2005: Increased charter capital to VND45.66 billion.

- 2008: Increased charter capital to VND64 billion;

- October 09, 2009: Officially traded on Hanoi Stock Exchange (HNX);

- 2013: Increased charter capital to VND93.32 billion.

ItemsUnit
PriceVND
VolumeShares
Foreigner's, Yield%
Mkt CapbVND
Financial indicatorsmVND
EPS, BVPS, DividendVND
P/E, F P/E, P/BTimes
ROS, ROA, ROE%
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
* Vietstock tổng hợp thông tin từ các nguồn đáng tin cậy vào thời điểm công bố cho mục đích cung cấp thông tin tham khảo. Vietstock không chịu trách nhiệm đối với bất kỳ kết quả nào từ việc sử dụng các thông tin này.